1,2-cyclohexanediamine has been researched along with quinoxalines in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellucci, C; Bolognesi, ML; Giorgi, G; Marucci, G; Matera, R; Melchiorre, C; Minarini, A; Rosini, M; Tumiatti, V | 1 |
Aldrich-Wright, JR; Ang, DL; Clegg, JK; Danchaiwijit, S; Kepert, CJ; Li, F; Pages, BJ; Spare, LK; Wormell, P | 1 |
2 other study(ies) available for 1,2-cyclohexanediamine and quinoxalines
Article | Year |
---|---|
Design, synthesis, and biological evaluation of pirenzepine analogs bearing a 1,2-cyclohexanediamine and perhydroquinoxaline units in exchange for the piperazine ring as antimuscarinics.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Cyclohexylamines; Gene Expression Regulation; Guinea Pigs; Heart Atria; Humans; Male; Models, Molecular; Molecular Structure; Muscarinic Antagonists; Muscle, Skeletal; Pirenzepine; Protein Binding; Quinoxalines; Rabbits; Receptors, Muscarinic; Structure-Activity Relationship; Vas Deferens | 2008 |
Synthesis and analysis of the anticancer activity of platinum(II) complexes incorporating dipyridoquinoxaline variants.
Topics: Animals; Antineoplastic Agents; Cattle; Cell Line, Tumor; Crystallography, X-Ray; Cyclohexylamines; DNA; Humans; Intercalating Agents; Models, Molecular; Neoplasms; Organoplatinum Compounds; Quinoxalines | 2014 |